Cytran Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cytran Inc.
Implicit giving second life to oglufanide
As a small, privately held biotech, the Australian venture Implicit Bioscience believes its business model has a number of advantages, low risk being chief among them.
Anti-Angiogenesis
Anti-angiogenesis as a treatment for cancer was hardly a new concept, even in 1998 when a New York Times article first put Judah Folkman's work on the public map. Although the hype has died away, the industrial machine of anti-angiogenesis has continued to roll on--as indicated by the start-up activity we describe in the following profiles.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice